JP2013527772A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527772A5 JP2013527772A5 JP2013510163A JP2013510163A JP2013527772A5 JP 2013527772 A5 JP2013527772 A5 JP 2013527772A5 JP 2013510163 A JP2013510163 A JP 2013510163A JP 2013510163 A JP2013510163 A JP 2013510163A JP 2013527772 A5 JP2013527772 A5 JP 2013527772A5
- Authority
- JP
- Japan
- Prior art keywords
- pla2
- subject
- level
- cvd
- determined
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33019310P | 2010-04-30 | 2010-04-30 | |
| US61/330,193 | 2010-04-30 | ||
| PCT/US2011/034728 WO2011137419A1 (en) | 2010-04-30 | 2011-05-02 | Methods using lipoprotein-associated phospholipase a2 in an acute care setting |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013527772A JP2013527772A (ja) | 2013-07-04 |
| JP2013527772A5 true JP2013527772A5 (enExample) | 2014-08-14 |
Family
ID=44861949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510163A Pending JP2013527772A (ja) | 2010-04-30 | 2011-05-02 | 急性期ケア環境においてリポタンパク質関連ホスホリパーゼａ２を使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20130236450A1 (enExample) |
| EP (1) | EP2563914A4 (enExample) |
| JP (1) | JP2013527772A (enExample) |
| CN (1) | CN103124785A (enExample) |
| CA (1) | CA2798122A1 (enExample) |
| WO (1) | WO2011137419A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7741020B2 (en) | 2004-04-16 | 2010-06-22 | Glaxo Group Limited | Methods for detecting Lp-PLA2 activity and inhibition of Lp-PLA2 activity |
| US20150017671A1 (en) | 2004-04-16 | 2015-01-15 | Yaping Shou | Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity |
| US20140283157A1 (en) | 2013-03-15 | 2014-09-18 | Diadexus, Inc. | Lipoprotein-associated phospholipase a2 antibody compositions and methods of use |
| WO2015123598A1 (en) * | 2014-02-14 | 2015-08-20 | Diadexus, Inc. | Biomarkers for cardiovascular disease |
| KR101629560B1 (ko) * | 2014-07-30 | 2016-06-13 | 경희대학교 산학협력단 | 부작용이 억제된 암치료용 약학 조성물 |
| US10900063B2 (en) | 2016-06-22 | 2021-01-26 | Asahi Kasei Pharma Corporation | Measurement of Lp-PLA2 activity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6161547A (en) * | 1999-01-15 | 2000-12-19 | Coaxia, Inc. | Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use |
| WO2004089184A2 (en) * | 2003-04-01 | 2004-10-21 | Diadexus, Inc. | NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK |
| AU2003902115A0 (en) * | 2003-05-02 | 2003-05-22 | The University Of Queensland | Method of predicting functional outcome of a stroke using eeg measures |
| CA2572795A1 (en) * | 2004-05-27 | 2005-12-08 | The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services | Differential expression of molecules associated with acute stroke |
| EP2166358A1 (en) * | 2008-09-17 | 2010-03-24 | Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron | Differential diagnostic biomarkers of stroke mimicking conditions and methods of use thereof |
-
2011
- 2011-05-02 JP JP2013510163A patent/JP2013527772A/ja active Pending
- 2011-05-02 WO PCT/US2011/034728 patent/WO2011137419A1/en not_active Ceased
- 2011-05-02 US US13/695,027 patent/US20130236450A1/en not_active Abandoned
- 2011-05-02 CN CN2011800326354A patent/CN103124785A/zh active Pending
- 2011-05-02 EP EP11775687.4A patent/EP2563914A4/en not_active Withdrawn
- 2011-05-02 CA CA2798122A patent/CA2798122A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nagamoto et al. | Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran | |
| Rallidis et al. | Right ventricular involvement in coronary artery disease: role of echocardiography for diagnosis and prognosis | |
| Galluzzo et al. | Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing | |
| JP2011162558A5 (enExample) | ||
| CA2798122A1 (en) | Methods using lipoprotein-associated phospholipase a2 in an acute care setting | |
| Aslan et al. | Flow in the left anterior descending coronary artery in patients with migraine headache | |
| Masugata et al. | Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension | |
| Besli et al. | Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion | |
| Mercier et al. | A reliable piglet model of chronic thrombo-embolic pulmonary hypertension | |
| Chen et al. | e0613 Plasma microRNA-361-5p as a biomarker of chronic heart failure | |
| Komar et al. | Elevated level of plasma endothelin-1 in patients with atrial septal defect | |
| Golan et al. | Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure—Therapy or Futility? | |
| Albers et al. | Postoperative non-invasive assessment of pulmonary vascular resistance using Doppler echocardiography | |
| Rahardjo | Correlation Between Left Atrial Enlargement and Left Ventricular Ejection Fraction in Hypertension Patients with and Without Atrial Fibrillation | |
| Kolesnyk | Diagnostic accuracy of C-terminal fragment of type I procollagen in detection of hidden heart failure in hypertensive males | |
| Schwaiblmair et al. | Characteristics Of Cardiopulmonary Exercise Parameters In Patients With Exercise-induced Pulmonary Artery Hypertension | |
| Ivanenko et al. | Dynamiсs of vascular stiffness parameters and central pressure on long-term antihypertensive therapy | |
| Hai et al. | ASSA13-16-6 The Increased Circulatory RAS Activity Can Be Inhibited by Statins | |
| Anderson et al. | Pulmonary Arteriovenous Malformations Presenting as Platypnea‐Orthodeoxia in Graft‐Versus‐Host Disease | |
| Следзевська et al. | Value of the exercise test in patients with postinfarction cardiosclerosis for evaluation of prognosis and efficiency of the rehabilitation treatment | |
| Yong et al. | ASSA13-16-3 Dyslipidemia in Chinese Elderly Patients with Acute Myocardial Infarction | |
| Hai et al. | ASSA13-16-4 The Influence of Combination of Amlodipine and Valsartan on Plasma Free Fat Acid and Adiponectin in Patients with Essential Hypertension | |
| Chenghong et al. | ASSA13-16-5 The Difference of Postprandial Plasma Triglyceride, Adiponectin and C-Reactive Protein Between Young and Middle Age Men | |
| Gao | ASSA13-16-2 Relationship Between Cholesteryl Ester Transfer Protein Gene–629C Æ A Mutations with HDL-C Levels and Coronary Heart Disease | |
| Suman et al. | Etiology of chronic heart failure in indian subjects |